z-logo
open-access-imgOpen Access
Cost-effectiveness of exome and genome sequencing for children with rare and undiagnosed conditions
Author(s) -
Tara A. Lavelle,
Xue Feng,
Marlena Keisler,
Joshua T. Cohen,
Peter J. Neumann,
Daryl Prichard,
Brock Schroeder,
Daria Salyakina,
Paula S. Espinal,
Samuel B Weidner,
Jill L. Maron
Publication year - 2022
Publication title -
genetics in medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.509
H-Index - 128
eISSN - 1530-0366
pISSN - 1098-3600
DOI - 10.1016/j.gim.2022.03.005
Subject(s) - medicine , pediatrics , medical diagnosis , exome sequencing , genetic testing , cost effectiveness , quality adjusted life year , mutation , genetics , pathology , risk analysis (engineering) , gene , biology
This study aimed to estimate the cost-effectiveness of exome sequencing (ES) and genome sequencing (GS) for children.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom